ExLibris header image
SFX Logo
Title: MRP is frequently expressed in human lung-cancer cell lines, in non-small-cell lung cancer and in normal lung
Source:

International Journal of Cancer [0020-7136] Giaccone, Giuseppe yr:1996


Collapse list of basic services Basic
Full text
Full text available via Wiley Online Library All Journals
GO
Full text available via Wiley Online Library Full Collection 2019
GO
Full text available via Wiley Online Library STM 2011
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Sugano, M. "Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice." Cancer research 60.24 (2000): 6942-9. Link to SFX for this item
2. Ponzoni, M. "Doxorubicin-loaded Fab' fragments of anti-disialoganglioside immunoliposomes selectively inhibit the growth and dissemination of human neuroblastoma in nude mice." Cancer research 63.1 (2003): 86-92. Link to SFX for this item
3. Huang, Shi K. "Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma." Cancer research 52.24 (1992): 6774-6781. Link to SFX for this item
4. Aina, Olulanu H H. "From combinatorial chemistry to cancer-targeting peptides." Molecular pharmaceutics 4.5 (2007): 631-51. Link to Full Text for this item Link to SFX for this item
5. Aina, Olulanu H H. "Therapeutic cancer targeting peptides." Biopolymers 66.3 (2002): 184-99. Link to Full Text for this item Link to SFX for this item
6. Jiao, P. "Leading neuroblastoma cells to die by multiple premeditated attacks from a multifunctionalized nanoconstruct." Journal of the American Chemical Society 133.35 (2011): 13918-21. Link to Full Text for this item Link to SFX for this item
7. ElBayoumi, Vladimir A. "Tumor-Targeted Nanomedicines: Enhanced Antitumor Efficacy In vivo of Doxorubicin-Loaded, Long-Circulating Liposomes Modified with Cancer-Specific Monoclonal Antibody." Clinical cancer research 15.6 (2009): 1973-1980. Link to SFX for this item
8. Schlimok, G. "Frequent down-regulation of major histocompatibility class I antigen expression on individual micrometastatic carcinoma cells." Cancer research 51.17 (1991): 4712-5. Link to SFX for this item
9. Pagnan, G. "GD2-mediated melanoma cell targeting and cytotoxicity of liposome-entrapped fenretinide." International journal of cancer 81.2 (1999): 268-74. Link to Full Text for this item Link to SFX for this item
10. Wester, Hans-Jürgen J. "Radiolabeled tracers for imaging of tumor angiogenesis and evaluation of anti-angiogenic therapies." Current pharmaceutical design 10.13 (2004): 1439-55. Link to SFX for this item
11. Rossjohn, J. "More than one reason to rethink the use of peptides in vaccine design." Nature reviews. Drug discovery 6.5 (2007): 404-14. Link to Full Text for this item Link to SFX for this item
12. Ko, J. "Preparation and characterization of chitosan microparticles intended for controlled drug delivery." International Journal of Pharmaceutics 298.1: 165-174. Link to SFX for this item
13. Cwirla, S E E. "Peptides on phage: a vast library of peptides for identifying ligands." Proceedings of the National Academy of Sciences of the United States of America 87.16 (1990): 6378-82. Link to Full Text for this item Link to SFX for this item
14. Allen, T. M. "Liposomes containing synthetic lipid derivatives of polyethylene glycol show prolonged circulation half-lives in vivo." Biochimica et biophysica acta. Biomembranes 1066.1 (1991): 29-36. Link to Full Text for this item Link to SFX for this item
15. Derfus, Austin M. "Targeted Quantum Dot Conjugates for siRNA Delivery." Bioconjugate chemistry 18.5 (2007): 1391-1396. Link to Full Text for this item Link to SFX for this item
16. Jain, R K K. "Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation." Nature medicine 3.2: 177-182. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced